05/13/2024
3:00 PM | Cormorant Asset Management, LP (Filed by)
CytomX Therapeutics (Subject)
| Form SC 13G | |
05/08/2024
3:41 PM | CytomX Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/01/2024
5:06 AM | CytomX Therapeutics (Filer)
| Form DEFA14A | |
04/04/2024
3:31 PM | CytomX Therapeutics (Filer)
| Form DEF 14A | |
04/04/2024
3:33 PM | CytomX Therapeutics (Filer)
| Form DEFA14A | |
03/28/2024
6:12 PM | CytomX Therapeutics (Issuer)
McCarthy Sean A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/25/2024
4:15 PM | CytomX Therapeutics (Filer)
| Form PRE 14A | |
|
03/22/2024
3:27 PM | CytomX Therapeutics (Issuer)
Su Zhen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2024
3:36 PM | CytomX Therapeutics (Issuer)
Landau Jeffrey B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2024
3:37 PM | BELVIN MARCIA (Reporting)
CytomX Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2024
3:38 PM | CytomX Therapeutics (Issuer)
Ogden Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2024
3:40 PM | CytomX Therapeutics (Issuer)
McCarthy Sean A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2024
3:41 PM | CytomX Therapeutics (Issuer)
ROWLAND LLOYD A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
3:30 PM | CytomX Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
01/19/2024
7:41 PM | CytomX Therapeutics (Issuer)
Ogden Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
7:43 PM | CytomX Therapeutics (Issuer)
ROWLAND LLOYD A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
7:44 PM | CytomX Therapeutics (Issuer)
McCarthy Sean A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
7:37 PM | Chu Yu-Waye (Reporting)
CytomX Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
7:38 PM | BELVIN MARCIA (Reporting)
CytomX Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
7:40 PM | CytomX Therapeutics (Issuer)
Landau Jeffrey B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/19/2023
6:54 PM | BELVIN MARCIA (Reporting)
CytomX Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/19/2023
6:55 PM | CytomX Therapeutics (Issuer)
ROWLAND LLOYD A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/19/2023
6:56 PM | CytomX Therapeutics (Issuer)
Landau Jeffrey B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/19/2023
6:57 PM | CytomX Therapeutics (Issuer)
McCarthy Sean A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/19/2023
6:58 PM | CytomX Therapeutics (Issuer)
Ogden Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/22/2023
6:12 PM | CytomX Therapeutics (Issuer)
ROWLAND LLOYD A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/22/2023
6:13 PM | CytomX Therapeutics (Issuer)
McCarthy Sean A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/22/2023
6:15 PM | CytomX Therapeutics (Issuer)
Landau Jeffrey B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/22/2023
6:16 PM | BELVIN MARCIA (Reporting)
CytomX Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/27/2023
11:15 PM | CytomX Therapeutics (Filer)
| Form EFFECT | |
08/24/2023
3:05 PM | CytomX Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/15/2023
8:40 PM | CytomX Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
07/20/2023
4:17 PM | Chu Yu-Waye (Reporting)
CytomX Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/20/2023
4:18 PM | Chu Yu-Waye (Reporting)
CytomX Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2023
3:06 PM | CytomX Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/16/2023
4:49 PM | CytomX Therapeutics (Issuer)
Jones Elaine V (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2023
4:49 PM | CytomX Therapeutics (Issuer)
Gilbert Halley E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2023
4:50 PM | Ashworth Alan (Reporting)
CytomX Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2023
4:51 PM | CytomX Therapeutics (Issuer)
Young Matthew P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2023
4:52 PM | CytomX Therapeutics (Issuer)
Mohindru Mani (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2023
4:54 PM | CytomX Therapeutics (Issuer)
Meyers James R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks (Ad) Are you monitoring 13,217 cryptocurrencies everyday?
If not, you could miss the ONE that can make you wealthy beyond your wildest dreams.
You see, while Bitcoin and Ethereum steal all the headlines… It’s often the cryptos flying under the radar that turn small stakes into life-changing windfalls. Claim your free seat by clicking here now. |
05/23/2023
3:52 PM | CytomX Therapeutics (Issuer)
McCarthy Sean A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
